Table 2.
Logistic regression analysis of baseline SUA levels and the development of CKD.
| SUA quartiles | Odds ratio (95% confidence interval) | |||
|---|---|---|---|---|
| Unadjusted | Model 1 | Model 2 | Model 3 | |
| Q1 (<4.8 md/dl) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Q2 (<5.7 mg/d) | 1.72 (1.00–2.96) | 1.93 (1.09–3.40) | 1.82 (1.02–3.25) | 1.79 (1.00–3.22) |
| Q3 (<6.5 mg/dl) | 3.29 (1.85–5.84) | 3.96 (2.13–7.35) | 3.53 (1.87–6.67) | 3.40 (1.79–6.47) |
| Q4 (≥6.5 mg/dl) | 5.4 (2.92–9.98) | 6.76 (3.44–13.25) | 6.43 (3.21–12.87) | 6.79 (3.45–13.75) |
| P for linear trend | <0.001∗ | <0.001∗ | <0.001∗ | <0.001∗ |
| SUA (per 1 mg/dl increase) | 1.66 (1.40–1.96) | 1.78 (1.47–2.15) | 1.74 (1.43–2.11) | 1.76 (1.45–2.14) |
| Normal SUA | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Hyperuricemia | 3.68 (2.11–6.40) | 3.58 (2.03–6.31) | 3.41 (1.91–6.09) | 3.68 (2.03–6.66) |
Model 1 was adjusted for age, sex, and BMI. Model 2 was adjusted for Model 1, TGs, TC, HDL. Model 3 was adjusted for Model 2, diabetes, hypertension, chronic cardiovascular disease, ACEI/ARB usage.